Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 4, 2006, Pages 370-373

  Al Salihi, O ^a   Mitra, A ^a   Payne, H ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

ADVANCED CANCER; BLADDER DISEASE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMPOTENCE; INTENSITY MODULATED RADIATION THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RECTUM DISEASE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; URINE INCONTINENCE;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 33751565315     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500893     Document Type: Review

References (15)

1. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974.
2. Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 2005; 92: 488-498.
3. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001; 166: 876-881.
4. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097-1105.
5. Bentzen SM, Ritter MA. The alpha/beta ratio for prostate cancer: What is it, really? Radiother Oncol 2005; 76: 1-3.
6. Kim Y, Hsu IC, Lessard E, Vujic J, Pouliot J. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys 2004; 59: 1208-1216.
7. Hoskin PJ, Bownes PJ, Ostler P, Walker K, Bryant L. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions. Radiother Oncol 2003; 68: 285-288.
8. Galalae RM, Martinez A, Mate T, Mitchell C, Edmundson G, Nuernberg N et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1048-1055.
9. Martin T, Roddiger S, Kurek R, Dannenberg T, Eckart O, Kolotas C et al. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. Radiother Oncol 2004; 71: 35-41.
10. Pellizzon AC, Nadalin W, Salvajoli JV, Fogaroli RC, Novaes PE, Maia MA et al. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 2003; 66: 167-172.
11. Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 59: 684-690.
12. Morton GC. The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol (R Coll Radiol) 2005; 17: 219-227.
13. Mate TP, Gottesman JE, Hatton J, Gribble M, Van Hollebeke L. High dose-rate afterloading 192Iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 1998; 41: 525-533.
14. Martinez AA, Gustafson G, Gonzalez J, Armour E, Mitchell C, Edmundson G et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53: 316-327.
15. Galalae RM, Kovacs G, Schultze J, Loch T, Rzehak P, Wilhelm R et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 2002; 52: 81-90.